Fundraising Fox

Esperante Ventures

Venture capital

London · Seed–Series A · 1 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Esperante Ventures is a venture investment firm owned by C&P Group Holdings, a private holding company focused on life sciences.

Source: firm website, verified Jul 31, 2026.

Stage
Seed–Series A
Check
$540K – $5.4M
HQ
London, GB
Instruments
Equity
Founded
2004
Tracked investments
1

Team · 1 people

from public directories

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Digital Health ×1Medical Devices ×1

Investments · 1 tracked

founders shown can be your intro path
Acousiaacousia.com

Acousia develops small molecule drug candidates with a dual mode of action to enhance and preserve natural hearing in patients with sensorineural hearing loss (SNHL), targeting indications such as age-related hearing loss, cisplatin-induced and aminoglycoside ototoxicity, and cochlear implant surgery.

BiotechDigital HealthMedical Devices

Co-investorsCreathor VenturesLBBW Venture Capital GmbHBoehringer Ingelheim Venture FundKfW

Frequently asked questions

What stage does Esperante Ventures invest at?
Esperante Ventures invests at the Seed, Series A stages.
What is Esperante Ventures's typical check size?
Esperante Ventures typically writes checks of $540K – $5.4M.
What sectors does Esperante Ventures focus on?
Esperante Ventures focuses on Biotech, Medical Devices.
Where is Esperante Ventures located?
Esperante Ventures is headquartered in London, GB.

Similar investors

Featured in lists